Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned.

PropertyValue
has major subject area list Antirheumatic Agents; Penicillamine; Scleroderma, Systemic
information resource reference Clements PJ, Seibold JR, Furst DE, Mayes M, White B, Wigley F, Weisman MD, Barr W, Moreland L, Medsger TA, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Wong WK. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned. Semin Arthritis Rheum. 2004 Feb; 33(4):249-63.
label High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned.

Search Criteria
  • Scleroderma Systemic

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)